Navigation Links
Sangamo BioSciences Reports Third Quarter 2011 Financial Results
Date:10/25/2011

gher expenses for our HIV/AIDS program.  General and administrative expenses were $3.6 million for the third quarter of 2011, compared to $2.9 million for the same period in 2010. The increase was primarily due to increased professional services expenses.

Total operating expenses for the third quarter of 2011 were $11.4 million, compared to $11.7 million for the same period in 2010.  

Nine Months ResultsFor the nine months ended September 30, 2011, the consolidated net loss was $29.4 million, or $0.59 per share, compared to a consolidated net loss of $16.5 million, or $0.37 per share, for the nine months ended September 30, 2010.  Revenues were $5.6 million for the nine months of 2011, compared to $16.1 million in the same period in 2010, with the decrease primarily due to the completion, in July 2010, of the amortization period for the commercial and research license fee received from Sigma under the expanded agreement of October 2009. Total operating expenses were $35.0 million for the nine months of 2011 and $32.7 million for the same period in 2010.

Financial Guidance

  • Cash, cash equivalents and marketable securities of at least $85 million at the end of 2011, exclusive of new funding from potential future partnerships.
  • Operating expenses for 2011 to be relatively flat compared to 2010, in the range of $43 to $47 million.
  • Revenues and related cash proceeds in the range of $10 to $12 million in 2011.

  • Recent Events

  • Announcement that Sangamo's Phase 2b Trial (SB-509-901) in Subjects with Moderately Severe Diabetic Neuropathy Did Not Meet Key Endpoints. Based on the data, the Company announced that it has discontinued further development of SB-509 and will focus resources on its pipeline including ZFP Therapeutics for HIV and monogenic diseases.
  • Presentation at ICAAC 2011 of Groundbreaking Clinical Data from Sangamo's Ongoing Phase 1 Clinical Trials
    '/>"/>

  • SOURCE Sangamo BioSciences, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Sangamo BioSciences Announces Third Quarter 2011 Conference Call and Webcast
    2. Sangamo BioSciences Announces Presentation at the 18th Annual Newsmakers in the Biotech Industry Conference
    3. Sangamo BioSciences Announces Presentation at the 2011 UBS Global Life Sciences Conference
    4. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
    5. Sangamo BioSciences Announces Efficient Generation of Transgenic Pigs Using Zinc Finger Nuclease (ZFN) Technology
    6. Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast
    7. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
    8. Sangamo Announces Pricing of Public Offering of Common Stock
    9. Sangamo Announces Public Offering of Common Stock
    10. Sangamo BioSciences and CHDI Foundation Announce Collaboration to Develop ZFP Therapeutic® for Huntingtons Disease
    11. Sangamo BioSciences Announces Presentation at the 10th Annual Needham Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... batteries that power our laptops and electric vehicles could ... charge with the help of a sponge-like silicon material. ... the graphite traditionally used in one of the battery,s ... energy storage capacity of graphite. A paper describing the ... today in Nature Communications . , "Silicon has ...
    (Date:7/10/2014)... will see the two universities and NPL collaborate to ... and industry and their complementary academic strengths., Working with ... shape the scientific priorities of the UK. The establishment ... 300 high-calibre PhD students, will provide a pipeline of ... potential of the Laboratory will be grown through the ...
    (Date:1/15/2014)... January 15, 2014 The Pittcon Organizing Committee ... Food Safety Tech , an e-Journal and producer of ... agreement for the second year for the co-location of Food ... The partnership provides that the registration fee to attend the ...
    (Date:1/15/2014)... California , January 15, 2014 Oxford ... today announced the appointment of Thomas C Reynolds MD, PhD ... years, development experience gained in the biotechnology industry, most recently ... am delighted to welcome Tom at this transformative time for ...
    Breaking Biology Technology:Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 2Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 3Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
    ... Reaching First Clinical Milestone Validates Approach, SAN ... successful completion of its first clinical trial, a,proof-of-concept ... a sodium channel blocker. Rufinamide was discovered and,developed ... in Europe as a,drug to treat a form ...
    ... January 22 Arpida Ltd.,(SWX: ARPN) announced today that ... with the TLT treatment in onychomycosis has been,initiated and ... 220 patients in total will be enrolled in this ... interest to,participate well in advance of the trial., ...
    ... nation,s top-10 GPOs(1), IRVINE, Calif., Jan. ... and Read-Through Motion and Low Perfusion pulse,oximetry, ... supplier agreement,with HealthTrust Purchasing Group (HealthTrust), representing ... ambulatory surgery,centers, alternate care sites and physician ...
    Cached Biology Technology:Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders 2Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders 3Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis 2Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis 3Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis 4Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 2Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 3Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 4
    (Date:7/10/2014)...  Unisys Corporation,s (NYSE: UIS ) subsidiary in ... announced that it has been selected by the Dutch Custodial ... Basic Provision Biometrics solution for penitentiaries across The ... with a solution based on its open standards-based LEIDA ... contract is up to seven years, with the new system ...
    (Date:7/10/2014)... -- According to the new market research ... Material (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application (Mobile ... Finance), and Geography - Global Trends & Forecasts to ... Sensors Market is projected to cross $14.35 Billion by ... 2014 to 2020. Browse more than 78 ...
    (Date:7/10/2014)... According to a new market ... Systems Market Global Forecast, Market Share, Size, Growth and ... Control systems market was valued at USD 15,406.1 million ... CAGR of 12.6% from 2014 to 2019, to reach ... Browse the full Electronic Access Control Systems ...
    Breaking Biology News(10 mins):Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3Fingerprint Sensors Market worth $14.35 Billion by 2020 2Fingerprint Sensors Market worth $14.35 Billion by 2020 3Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 2Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 3Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 4Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 5
    ... PARK, Md. - Offshore wind power offers a feasible ... goals, but presents some economic and political hurdles, concludes ... for Integrative Environmental Research (CIER). The study, " ... feasibility assessment to date of developing and operating wind ...
    ... large role in cleansing the atmosphere, a new study ... National Center for Atmospheric Research (NCAR) in Boulder, Colo., ... show that deciduous plants absorb about a third more ... thought. The new study, results of which are ...
    ... 2010 A multi-institutional consortium led by The Scripps Research ... the sole focus of a special issue of the journal ... the history of the monthly journal, which publishes peer-reviewed crystallography ... to the works of a single scientific center. ...
    Cached Biology News:Offshore wind a 'mixed bag': University of Maryland study 2Offshore wind a 'mixed bag': University of Maryland study 3Plants play larger role than thought in cleaning up air pollution 2Plants play larger role than thought in cleaning up air pollution 3Entire issue of scientific journal devoted to center headed by Scripps Research Scientists 2Entire issue of scientific journal devoted to center headed by Scripps Research Scientists 3Entire issue of scientific journal devoted to center headed by Scripps Research Scientists 4Entire issue of scientific journal devoted to center headed by Scripps Research Scientists 5
    ... marker mix was designed specifically to aid the ... a complement of seven reduced and denatured proteins ... who use markers to assess 2-D system performance ... proteins undergoing 2-D separation and analysis. , ...
    ... The DNA Engine Tetrad thermal cycler ... the pioneering PTC-200 DNA Engine cycler. ... the capacity with a footprint only ... throughput for laboratories that run massive ...
    The sealed ice cooling unit is used to absorb heat that is generated during transfers performed in the Criterion blotter....
    The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system....
    Biology Products: